Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. rendering
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Rendering Articles & Analysis: Older

43 news found

Protheragen-ING Unveils Its Most Popular Active Pharmaceutical Ingredients

Protheragen-ING Unveils Its Most Popular Active Pharmaceutical Ingredients

The implications of Trilostane’s ability to modulate steroid conversion render it a valuable asset in cortisone research and related scientific inquiries. ...

ByProtheragen-ING


Creative BioMart Updated Its R-PEAPC Conjugated Proteins for Research Use

Creative BioMart Updated Its R-PEAPC Conjugated Proteins for Research Use

Advantages of Creative BioMart’s R-PE Labeled Proteins ● Strong stability ● Stable fluorescence signals ● Strong color rendering ● Low false positive rates ● Easy to operate ● Customized to meet your experimental needs According to Linna, the chief marketing staff at Creative BioMart, the company can also conjugate specific recombinant proteins based on ...

ByCreative BioMart


Medicalgorithmics Announces Hiring of Medical Device Commercial Veteran James Landis as Vice President Sales and Business Development of North America

Medicalgorithmics Announces Hiring of Medical Device Commercial Veteran James Landis as Vice President Sales and Business Development of North America

We will also be granting licenses for the use of our software, including our advanced algorithms rendered on a non-exclusive basis. The strategy also seeks to reach new sales channels, ultimately increasing revenue by offering services to a larger number of patients and providing additional opportunities for growth in launching new services. ...

ByMedicalgorithmics S.A.


Frontier Biotech opens a new manufacture facility in Chengdu - Aikening, a novel long-acting HIV medicine, receives a production capability boost

Frontier Biotech opens a new manufacture facility in Chengdu - Aikening, a novel long-acting HIV medicine, receives a production capability boost

On July 15, 2021, The openning ceremony of a new state of the art peptide manufacture facility was held in Jintang, Chengdu. The successful completion of the facility marks the successful industrialization of Aikening® in Jintang. Aiming at intelligent manufacturing, high efficiency and eco system, and a quality system to be certified by the US FDA, EU EMA and China NMPA, the peptide ...

ByFrontier Biotechnologies Inc.


An Easy, Predictable, and Simpler Way to Embolize Tumors

An Easy, Predictable, and Simpler Way to Embolize Tumors

In other words, a seemingly contradictory combination of requirements: the same material can set up in water, absorb in water, and be rendered inactive in water, which is all achievable because of Sawhney and his team’s expertise in hydrogels. ...

ByInstylla, Inc.


CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis

CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis

PyMOL is a powerful and comprehensive molecular visualization system that allows the vision of molecular structures in 3-D formats, renders figures artistically, and animates molecules dynamically. This molecular viewer includes a "one window" native user interface, numerous built-in tools, and additional features to assist in customizing 3-D biomolecular images. ...

ByCD ComputaBio


Ondine’s photodisinfection kills ESKAPE pathogens

Ondine’s photodisinfection kills ESKAPE pathogens

“Overuse of antibiotics over decades has caused adaptation in many microbes, and we now see multidrug resistance (MDR) evolving into extensive drug resistance (XDR) in bacteria, rendering even the most powerful drugs we have ineffective,” stated Dr. ...

ByOndine Biomedical Inc


How the COVID-19 PCR Test Works

How the COVID-19 PCR Test Works

The use of products from the previous cycles as templates, renders the amplification exponential (2 copies, 4, 16, 32, etc), but reaches a plateau (flat line) when the ingredients we initially put in run out. ...

BymiDIAGNOSTICS


ConcertAI’s TeraRecon Accelerates Multi-Specialty Advanced Visualization Capabilities with the Launch of Intuition 4.6

ConcertAI’s TeraRecon Accelerates Multi-Specialty Advanced Visualization Capabilities with the Launch of Intuition 4.6

Among the advanced capabilities, glow rendering offers a photorealistic presentation of 3D structures. Patient list filtering and list flags enable customized searches of patient lists simplifying workflow for practitioners, and enhanced tools for clinical measurements, treatment planning, and diagnosis. ...

ByTeraRecon, Inc.


Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results

Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results

The agreement provides for reimbursement rates at a percent of charges for services rendered, including the performance of the EsoGuard test. Medicare Administrative Contractor Palmetto GBA’s MolDX Program published a proposed foundational Local Coverage Determination (“LCD”) for tests designed to detect upper gastrointestinal precancer and cancer, an important ...

ByPAVmed Inc.


Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans

Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans

The agreement provides rates of reimbursement as a percent of charges for services rendered to such covered persons by LucidDx Labs, including performance of the EsoGuard test. ...

ByPAVmed Inc.


BioXcel Therapeutics Announces Formation of OnkosXcel Therapeutics to Develop Medicines Focused in Oncology

BioXcel Therapeutics Announces Formation of OnkosXcel Therapeutics to Develop Medicines Focused in Oncology

Approved and experimental immunotherapies often struggle to address cancers that appear “cold” or uninflamed. Therefore, BXCL701 may render “cold” tumors “hot,” making them more detectable by the adaptive immune system and thereby facilitating the development of a strong anti-cancer immune response. ...

ByBioXcel Therapeutics, Inc.


LIXTE Biotechnology Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations

LIXTE Biotechnology Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations

In brief, LIXTE’s first-in-class lead clinical compound and protein phosphatase 2A (PP2A) inhibitor, LB-100, induces further activation of oncogenic signaling in a number of KRAS-mutant cancers, rendering them particularly vulnerable to anti-cancer therapy. Professor Bernards’ presentation, entitled “Unconventional Approaches to the Treatment of Cancer”, ...

ByLIXTE Biotechnology Holdings, Inc.


Despite COVID-19 Hospital Quarantines, Nurses Find a Way to Implement Mission-Critical Clinical Systems Across Seven States to Make Childbirth Safer

Despite COVID-19 Hospital Quarantines, Nurses Find a Way to Implement Mission-Critical Clinical Systems Across Seven States to Make Childbirth Safer

A Remote Clinical Lead Named “Flo” Helps Hospitals Implement Early Warning and Telehealth Tools Designed to Help Nurses Manage Patients; Delivers a Welcome Distraction While clinicians rely more than ever on technology to help provide adequate care safely, hospital quarantines have rendered it near impossible to deploy new tools at the bedside, until Flo. ...

ByPeriGen, Inc.


MicrobioSeq Releases PCR-based Microbial Antibiotic Resistance Gene Analysis Service

MicrobioSeq Releases PCR-based Microbial Antibiotic Resistance Gene Analysis Service

There is concern that the rapid global spread of multi-drug-resistant and pan-drug-resistant bacteria (also known as "superbugs") may render some infections untreatable with existing antimicrobial drugs such as antibiotics. ...

ByCD Genomics


BioXcel Therapeutics Presents Positive Data from Phase 2 Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2022 ASCO Genitourinary Cancers Symposium

BioXcel Therapeutics Presents Positive Data from Phase 2 Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2022 ASCO Genitourinary Cancers Symposium

Approved and experimental immunotherapies often struggle to address cancers that appear “cold” or uninflamed. Therefore, BXCL701 may render “cold” tumors “hot,” making them more detectable by the adaptive immune system and thereby facilitating the development of a strong anti-cancer immune response. ...

ByBioXcel Therapeutics, Inc.


FUJIFILM VisualSonics and PIUR IMAGING Partner to Enable Ultra-High Frequency, 3D Ultrasound Imaging Technology

FUJIFILM VisualSonics and PIUR IMAGING Partner to Enable Ultra-High Frequency, 3D Ultrasound Imaging Technology

” PIUR tUS Infinity is a wireless add-on solution, consisting of a patented sensor-based tracking unit, a video transmission box, and software for image analysis and 3D rendering. When combined with FUJIFILM VisualSonics’ Vevo MD ultrasound imaging system, this produces three-dimensional UHF ultrasound volumetrics. ...

ByFUJIFILM VisualSonics, Inc.


Align Technology Continues to Revolutionize Orthodontic and Restorative Dental Treatment Planning With Invisalign System Innovations For the Align Digital Platform That Enhance Practice Efficiency, Doctor-Patient Engagement, and Treatment Outcomes

Align Technology Continues to Revolutionize Orthodontic and Restorative Dental Treatment Planning With Invisalign System Innovations For the Align Digital Platform That Enhance Practice Efficiency, Doctor-Patient Engagement, and Treatment Outcomes

With the powerful ClinCheck In-Face Visualization tool, doctors receive a facial rendering that they can use for treatment planning and help patients visualize their smile after both Invisalign treatment and restorative dental treatment. ...

ByAlign Technology, Inc.


Positron Investor Update

Positron Investor Update

The technology consists of 4D image renderings vs the 3D images of our competitors, significant improvement acquisition times and greater image resolution, LYSO crystals, more robust software to include coronary flow reserve analysis, novel image registration, proprietary reconstruction algorithms and a 64 slice CT. ...

ByPositron Corporation


Lixte Biotechnology Announces Filing of First Patent Application Resulting from Collaboration with the Netherlands Cancer Institute and the Oncode Institute to Identify the Most Promising Drug Combinations for Lead Clinical Compound, LB-100

Lixte Biotechnology Announces Filing of First Patent Application Resulting from Collaboration with the Netherlands Cancer Institute and the Oncode Institute to Identify the Most Promising Drug Combinations for Lead Clinical Compound, LB-100

Kovach, MD, the founder and CEO of Lixte, commented "The new findings support the hypothesis advanced by Professor Bernards at the NKI (Dias and Bernards, Mol Onc, 2021) that rather than the usual therapeutic approach to cancer – inhibiting overactive pathways that drive cancer growth – further stimulation of those pathways can overwhelm the cancer cells, rendering ...

ByLIXTE Biotechnology Holdings, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT